Search
Now showing items 1-5 of 5
Underreporting of Adverse Drug Events: a Look into the Extent, Causes, and Potential Solutions
(Taylor and Francis Ltd., 2023)
Adverse drug events (ADEs) represent a global public health challenge that impacts both patients and healthcare systems alike. ADE is defined as any harm caused by medication that could potentially be prevented ...
Pharmacokinetic interaction of rosuvastatin with artichoke (Cynara scolymusL.) leaf extract in rats
(Open Science Publishers LLP Inc., 2023)
Dyslipidemia is a prevalent disease among the international population that has substantially increased, which can be treated with several hypolipidemic drugs such as rosuvastatin. Artichoke is a plant that is commonly ...
Technical and regulatory challenges of digital health implementation in developing countries
(Taylor and Francis Ltd., 2023)
Over the past two decades, healthcare services have been revolutionized by integrating information technology tools into medical settings worldwide, with the aim of improving the quality of care and saving resources. These ...
Artificial intelligence (AI) in pharmacy: an overview of innovations
(Taylor and Francis Ltd., 2023)
Pharmacies, if properly equipped, have the potential to
evolve into health management centers rather than mere
medication fulfillment locations. Recent years have witnessed an exponential surge in data digitization within ...
How AI is advancing asthma management? Insights into economic and clinical aspects
(Taylor and Francis Ltd., 2023)
Asthma, an increasingly prevalent chronic respiratory condition, incurs significant economic costs worldwide. Artificial Intelligence (AI), particularly Machine Learning (ML), has been widely recognized as transformative ...